Breaking News Instant updates and real-time market news.

SSNLF

Samsung

, QCOM

Qualcomm

$66.68

-0.43 (-0.64%)

06:23
10/05/16
10/05
06:23
10/05/16
06:23

Samsung to be sole manufacturer for Qualcomm's new Snapdragon chip, Reuters says

Samsung (SSNLF) is expected to be the lone contract manufacturer for Qualcomm's (QCOM) next high-end Snapdragon chips, Reuters reports, citing South Korea's Electronic Times. According to unnamed sources, the Electronic Times said Samsung will produce Qualcomm's Snapdragon 830 mobile processors using 10-nanometre production technology, and said Samsung agreed to use the processors in half of its next update of the Galaxy S smartphone that will launch in 2017. Reference Link

SSNLF

Samsung

QCOM

Qualcomm

$66.68

-0.43 (-0.64%)

  • 23

    Oct

SSNLF Samsung

04/13/16
ROTH
04/13/16
NO CHANGE
Target $2.6
ROTH
Buy
Digital Turbine estimates, price target reduced at Roth Capital
Roth Capital analyst Brian Alger reduced his estimates for Digital Turbine (APPS) and lowered his price target on the shares to $2.60 from $3, after the company quantified the miss that it had previewed last month. The shortfall was attributed to the slashed digital ad budget of a large advertising customer, Verizon (VZ) choosing to reduce the number of slots per device for much of the March quarter, and to Verizon Samsung S7's (SSNLF) that have yet to have Ignite software included, the analyst tells investors in a research note. Alger reiterates a Buy rating on Digital Turbine's shares, considering the depressed current valuation.
04/26/16
NEED
04/26/16
NO CHANGE
NEED
Apple supply chain names to rebound, says Needham
Needham analyst Rajvindra Gill expects a rebound in the Apple (AAPL) supply chain names given its underperformance over the last 25 days and the relatively good quarterly results from Knowles (KN). Among the names, the analyst sees Cirrus Logic (CRUS) increasing its dollar content per unit about 40% for the iPhone 7 cycle, with possible upside of 80%-100% for the iPhone 7S in 2017 with the inclusion of adaptive noise cancellation. Knowles, which generated 25% of sales from Apple and less than 10% of sales from Samsung (SSNLF), posted better-than-expected results and guidance, the analyst tells investors in a research note.
06/23/16
BFIN
06/23/16
NO CHANGE
BFIN
Fitbit faces 'fight of its life,' GoPro Karma delay a problem, says BlueFin
In an update on the wearable space, BlueFin analysts John Donovan and Steve Mullane make the case that Fitbit (FIT) is "in for the fight of its life" given mounting competition that is coming from Samsung (SSNLF), Apple (AAPL), Garmin (GRMN) and Under Armour (UA), adding that the sizable inventory of Alta and Blaze devices that it must deplete in this competitive environment puts Fitbit is in a "precarious position." The analyst add that Apple's watchOS improvements "further paint Fitbit into a corner," but noted that market data suggests consumers are looking for wearables under $200, which is in the "sweet spot" of Fitbit's portfolio. Weighing in on GoPro (GPRO), the analysts wonder if the Hero5 will be compelling enough to make consumers buy another camera and note that its upcoming Karma drone is very late to market and "facing daunting odds."
08/01/16
NEED
08/01/16
NO CHANGE
Target $65
NEED
Buy
Synaptics price target lowered to $65 from $88 at Needham
Needham analyst Rajvindra Gill lowered his price target for Synaptics (SYNA) to $65 from $88 on a lower earnings multiple as he remains uncertain on whether the company has secured the OLED DDIC for Apple's (AAPL) iPhone 8 versus an internal Samsung (SSNLF) solution. The analyst reiterates a Buy rating on Synaptics' shares, saying the company will remain one of the leaders in the display markets.
QCOM Qualcomm
$66.68

-0.43 (-0.64%)

09/30/16
09/30/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded on potential NXP Semiconductors acquisition at Mizuho with the firm's analyst saying he believes a Qualcomm acquisition of NXP Semiconductors (NXPI) makes significant strategic and financial sense. 2. Skechers (SKX) upgraded to Positive from Neutral at Susquehanna. 3. Sprouts Farmers Markets (SFM) upgraded to Buy from Hold at Jefferies with analyst Christopher Mandeville saying the risk/reward is now favorable following the recent pullback in the shares. 4. Phillips 66 (PSX) upgraded to Neutral from Sell at Goldman with analyst Neil Mehta citing higher multiple assumptions for midstream and chemicals segments, reduced capex spending and higher free cash flow estimates, and more achievable consensus expectations. 5. NetApp (NTAP) upgraded to Buy from Sell at Summit Redstone with analyst Srini Nandury citing optimism that the company can grow its product revenue from current levels driven by AFA sales and increasing adoption of clustered ONTAP. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/30/16
OPCO
09/30/16
NO CHANGE
OPCO
NXP 'cheap' for Qualcomm even after rally, says Oppenheimer
Oppenheimer analyst Rick Schafer says NXP Semiconductors (NXPI) still a "cheap" takeover target for Qualcomm (QCOM) even after rallying 25% over the past two days. An acquisition would be accretive to Qualcomm's earnings "under most scenarios," the analyst tells investors in an intraday research note. He thinks Qualcomm needs to diversify away from handsets and has $31B of offshore cash, the analyst contends. Schafer keeps a Perform rating on Qualcomm.
10/03/16
UBSW
10/03/16
NO CHANGE
Target $59
UBSW
Neutral
Qualcomm acquisition of NXP Semiconductors would be positive, says UBS
UBS analyst Stephen Chin said he would view an acquisition of NXP Semiconductors (NXPI) by Qualcomm (QCOM) as positive citing such a deals likely accretion, as well as benefits like sales diversification, its patent portfolio and cash flow generation. Chin maintains his Neutral rating and $59 price target on Qualcomm shares.
10/03/16
RBCM
10/03/16
NO CHANGE
Target $70
RBCM
Sector Perform
RBC says $120-130/share seems like high end of reasonable Qualcomm price for NXP
RBC analyst Amit Daryanani believes $120-$130 per share is likely the "upper end of the valuation framework" that Qualcomm (QCOM) would like to pay in any potential deal to acquire NXP Semiconductors (NXPI). While Qualcomm "can certainly elect to pay a larger premium" than that, doing so would likely come in the form of Qualcomm equity issuance, which would impede the accretion from the deal, Daryanani tells investors. The analyst keeps a Sector Perform rating on Qualcomm shares, but raised his price target on the stock to $70 from $59 citing the potential for diversification and higher cash flow generation that an NXP deal would provide.

TODAY'S FREE FLY STORIES

FCAU

Fiat Chrysler

$11.65

1.11 (10.53%)

, GOOG

Alphabet

$871.73

-0.57 (-0.07%)

06:51
04/27/17
04/27
06:51
04/27/17
06:51
Periodicals
Fiat Chrysler seeks more self-driving supplier partners, Reuters reports »

Fiat Chrysler (FCAU) is…

FCAU

Fiat Chrysler

$11.65

1.11 (10.53%)

GOOG

Alphabet

$871.73

-0.57 (-0.07%)

GOOGL

Alphabet Class A

$889.14

0.3 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 16

    May

  • 22

    May

NTDOY

Nintendo

$31.05

-0.6 (-1.90%)

06:51
04/27/17
04/27
06:51
04/27/17
06:51
Earnings
Nintendo reports FY16 profit per share Y853.87 vs. Y137.4 last year »

Reports FY16 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

06:50
04/27/17
04/27
06:50
04/27/17
06:50
General news
Front-month WTI crude prices are down 1% »

Front-month WTI crude…

EXAS

Exact Sciences

$23.80

-1.09 (-4.38%)

06:50
04/27/17
04/27
06:50
04/27/17
06:50
Technical Analysis
Exact Sciences hits new 52-week high after results »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 30

    May

  • 06

    Jun

BWA

BorgWarner

$41.06

0.22 (0.54%)

06:49
04/27/17
04/27
06:49
04/27/17
06:49
Earnings
BorgWarner now sees FY17 EPS $3.50-$3.60, consensus $3.41 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

SDPI

Superior Drilling

$0.79

-0.0099 (-1.24%)

06:49
04/27/17
04/27
06:49
04/27/17
06:49
Earnings
Breaking Earnings news story on Superior Drilling »

Superior Drilling sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOW

Dow Chemical

$64.33

-0.48 (-0.74%)

06:48
04/27/17
04/27
06:48
04/27/17
06:48
Hot Stocks
Breaking Hot Stocks news story on Dow Chemical »

Dow Chemical reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

  • 11

    May

DOW

Dow Chemical

$64.33

-0.48 (-0.74%)

06:48
04/27/17
04/27
06:48
04/27/17
06:48
Hot Stocks
Dow Chemical reports Q1 EBITDA $2.1B »

Q1 operating EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

  • 11

    May

BWA

BorgWarner

$41.06

0.22 (0.54%)

06:47
04/27/17
04/27
06:47
04/27/17
06:47
Earnings
BorgWarner sees Q2 EPS 87c-91c, consensus 87c »

Sees Q2 organic net sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

RHHBY

Roche

$32.20

-0.207 (-0.64%)

06:47
04/27/17
04/27
06:47
04/27/17
06:47
Hot Stocks
Roche CEO Severin Schwan says 'well on track' to meet full-year targets »

Commenting on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 06

    Jun

  • 26

    Jun

RHHBY

Roche

$32.20

-0.207 (-0.64%)

06:46
04/27/17
04/27
06:46
04/27/17
06:46
Earnings
Roche reports Q1 group sales CHF12.94B vs. CHF12.41B last year »

Group sales increased 4%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 06

    Jun

  • 26

    Jun

BWA

BorgWarner

$41.06

0.22 (0.54%)

06:46
04/27/17
04/27
06:46
04/27/17
06:46
Earnings
BorgWarner reports Q1 EPS 89c, consensus 84c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

XRF

China Rapid Finance

06:45
04/27/17
04/27
06:45
04/27/17
06:45
Syndicate
China Rapid Finance 10M share IPO price range lowered to $6.00-$7.00 »

China Rapid Finance 10M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

DOW

Dow Chemical

$64.33

-0.48 (-0.74%)

06:45
04/27/17
04/27
06:45
04/27/17
06:45
Earnings
Dow Chemical reports Q1 operating EPS $1.04, consensus 98c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

  • 11

    May

HP

Helmerich & Payne

$65.21

-0.18 (-0.28%)

06:45
04/27/17
04/27
06:45
04/27/17
06:45
Earnings
Helmerich & Payne reports Q2 EPS (45c) with items, consensus (40c) »

Reports Q2 revenue $405M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

RHHBY

Roche

$32.20

-0.207 (-0.64%)

06:44
04/27/17
04/27
06:44
04/27/17
06:44
Hot Stocks
Roche confirms FY17 outlook, sees sales up low to mid single digits »

In 2017, Roche expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 06

    Jun

  • 26

    Jun

BSX

Boston Scientific

$25.97

0.23 (0.89%)

06:44
04/27/17
04/27
06:44
04/27/17
06:44
Earnings
Boston Scientific baks FY17 adj. EPS view of $1.22-$1.26, consensus $1.25 »

Raises FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 07

    Jun

  • 27

    Jun

AKAM

Akamai

$62.24

0.44 (0.71%)

06:43
04/27/17
04/27
06:43
04/27/17
06:43
Downgrade
Akamai rating change  »

Akamai downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 08

    Jun

  • 15

    Jun

CSCO

Cisco

$33.40

-0.02 (-0.06%)

, SPLK

Splunk

$63.72

-0.13 (-0.20%)

06:43
04/27/17
04/27
06:43
04/27/17
06:43
Upgrade
Credit Suisse double upgrades Cisco on possible M&A transformation »

Cisco Systems'…

CSCO

Cisco

$33.40

-0.02 (-0.06%)

SPLK

Splunk

$63.72

-0.13 (-0.20%)

NOW

ServiceNow

$90.92

0.68 (0.75%)

PANW

Palo Alto Networks

$109.27

-1.13 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 12

    Jun

WCC

WESCO

$68.00

0.6 (0.89%)

06:42
04/27/17
04/27
06:42
04/27/17
06:42
Earnings
WESCO sees Q2 sales down 2% to up 1%, consensus $1.92B »

Sees Q2 operating margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

  • 07

    Jun

WCC

WESCO

$68.00

0.6 (0.89%)

06:42
04/27/17
04/27
06:42
04/27/17
06:42
Earnings
WESCO backs FY17 EPS $3.60-$4.00, consensus $3.87 »

Backs FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

  • 07

    Jun

BSX

Boston Scientific

$25.97

0.23 (0.89%)

06:42
04/27/17
04/27
06:42
04/27/17
06:42
Earnings
Boston Scientific reports Q1 adj. EPS 29c, consensus 30c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 07

    Jun

  • 27

    Jun

ICLR

ICON plc

$76.83

-0.54 (-0.70%)

06:42
04/27/17
04/27
06:42
04/27/17
06:42
Earnings
ICON plc raises FY17 EPS view to $5.06-$5.26 from $5.00-$5.20, consensus $5.10 »

Backs FY17 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

EXAS

Exact Sciences

$23.80

-1.09 (-4.38%)

06:41
04/27/17
04/27
06:41
04/27/17
06:41
Hot Stocks
Exact Sciences sign collaboration agreement with MDxHealth »

MDxHealth announced that …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 30

    May

  • 06

    Jun

STAY

Extended Stay America

$17.45

0.26 (1.51%)

06:41
04/27/17
04/27
06:41
04/27/17
06:41
Hot Stocks
Extended Stay America declares Q1 distribution of 21c per share »

Extended Stay America and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.